In This Issue:

Table of Contents:

Introduction; Provisions Affecting Pharmaceutical Manufacturers; Medicaid Rebate and Related Sections; Medicare Part D Prescription Drug Benefit Sections; Public Health Service Section 340B Discounts; Pharmaceutical Industry Fees; Medicaid Exclusion from Participation Relating to Certain Ownership, Control, and Management Affiliations (Sec. 6502); Provisions Affecting Device Manufacturers; Medical Device Excise Taxes; Durable Medical Equipment, Prosthetics, Orthotics and Supplies; Provisions Affecting Biotech Entities; Payment for Biosimilar Biological Products; Abbreviated Approval Pathway for Follow-On Biologics; Qualifying Therapeutic Discovery Project Credit; Provisions Affecting All Manufacturers; Transparency Reports and Reporting of Physician Ownership or Investment Interests; Comparative Clinical Effectiveness Research; Cures Acceleration Network; Conclusion; and Contributors.

Please see full newsletter below for more information.